MobiHealth News July 26, 2019
Laura Lovett

MassBio’s Luba Greenwood also discusses her decision to leave Verily in order to pursue teaching the intersection of life science and technology at Harvard.

Digital health is still somewhat of an enigma to many in the traditional world of pharma, but that is rapidly changing. As the use cases for digital tools continues to evolve, the life science world is starting to make a concerted effort to engage the new technologies.

This growing digital health ecosystem is now a major conversation point at MassBio, an organization dedicated to advancing the state of Massachusetts’ leadership in the life science industry and adding value to the healthcare system.

“With the convergences of life...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Precision Medicine, Technology
A year has passed -- Besides AI everywhere, what (else) has changed?
Getting Patients in the Habit of Doing the Right Thing
Teladoc expands virtual sitter capabilities
UK digital health funding should be ringfenced, says report
How Nurses Can Lead Innovation

Share This Article